Dollar cost averaging (DCA) in RAPP means investing a fixed amount at regular intervals, regardless of share price. This strategy reduces timing risk and builds wealth steadily through market ups and downs.
How This Calculator Works
Our DCA calculator simulates real market conditions using historical price data. It accounts for dividend reinvestment (DRIP), where each dividend payment automatically purchases additional shares. You can adjust the investment amount, frequency, time period, and compare against benchmarks like the S&P 500 and Nasdaq-100.
More RAPP Analysis
RAPP DCA Calculator
Dollar Cost Averaging — Rapport Therapeutics, Inc. Common Stock
Same amount invested each month — only the day of purchase changes. How much does intra-month timing actually matter?
Best Timing DCA
StrategyBuy on monthly low
Total Return+112.5%
Final Value$45.7K
Perfectly timed — impossible in practice
Your DCA
StrategyBuy on 1st of month
Total Return+92.2%
Final Value$40.4K
Consistent — no timing needed
Worst Timing DCA
StrategyBuy on monthly high
Total Return+76.9%
Final Value$38.0K
Worst possible — still beats not investing
Best vs Worst gap35.6 pp
Your timing vs best-20.3%
Your timing vs worst+15.3%
If You Keep Investing…
Based on this stock's historical CAGR of 40.8%/yr — put in vs. walk away with.
Your Plan
At $500/mo, this could grow into:
3 Years$31K~1.7x your moneyfrom $18K invested
5 Years$78K~2.6x your moneyfrom $30K invested
10 Years$511K~8.5x your moneyfrom $60K invested
20 Years$16.1M~134.5x your moneyfrom $120K invested
Compare Other Monthly Amounts
Same CAGR assumption. Use this to pressure-test different monthly commitments.
Monthly
3 Years~1.7x your money
5 Years~2.6x your money
10 Years~8.5x your money
20 Years~134.5x your money
$100/mo
$6K+$3K est. gain
$16K+$10K est. gain
$102K+$90K est. gain
$3.2M+$3.2M est. gain
$250/mo
$15K+$6K est. gain
$39K+$24K est. gain
$256K+$226K est. gain
$8.1M+$8.0M est. gain
$500/mo
$31K+$13K est. gain
$78K+$48K est. gain
$511K+$451K est. gain
$16.1M+$16.0M est. gain
$1,000/mo
$62K+$26K est. gain
$157K+$97K est. gain
$1.0M+$903K est. gain
$32.3M+$32.0M est. gain
* Projection assumes historical CAGR of 40.8% continues. Actual returns will vary.
Your DCA Results by Date
23 purchases
Date
Price
Invested
Portfolio Value
% Gain
Gain ($)
Jun 7, 2024
$20.80
$10,000
$10,000
+0.00%
$0
Jul 8, 2024
$24.27
$10,500
$12,168
+15.89%
$1,668
Aug 7, 2024
$18.86
$11,000
$9,956
-9.49%
$-1,044
Sep 9, 2024
$19.66
$11,500
$10,878
-5.41%
$-622
Oct 7, 2024
$21.04
$12,000
$12,142
+1.18%
$142
Nov 7, 2024
$26.90
$12,500
$16,023
+28.19%
$3,523
Dec 9, 2024
$20.53
$13,000
$12,729
-2.08%
$-271
Jan 7, 2025
$17.79
$13,500
$11,530
-14.59%
$-1,970
Feb 7, 2025
$16.13
$14,000
$10,954
-21.76%
$-3,046
Mar 7, 2025
$8.59
$14,500
$6,334
-56.32%
$-8,166
Apr 7, 2025
$9.51
$15,000
$7,512
-49.92%
$-7,488
May 7, 2025
$10.22
$15,500
$8,573
-44.69%
$-6,927
Jun 9, 2025
$12.71
$16,000
$11,162
-30.24%
$-4,838
Jul 7, 2025
$12.04
$16,500
$11,073
-32.89%
$-5,427
Aug 7, 2025
$15.41
$17,000
$14,673
-13.69%
$-2,327
Sep 8, 2025
$31.47
$17,500
$30,464
+74.08%
$12,964
Oct 7, 2025
$26.44
$18,000
$26,095
+44.97%
$8,095
Nov 7, 2025
$25.66
$18,500
$25,825
+39.59%
$7,325
Dec 8, 2025
$30.16
$19,000
$30,854
+62.39%
$11,854
Jan 7, 2026
$30.12
$19,500
$31,313
+60.58%
$11,813
Feb 9, 2026
$27.28
$20,000
$28,861
+44.30%
$8,861
Mar 9, 2026
$30.54
$20,500
$32,809
+60.05%
$12,309
Apr 7, 2026
$33.49
$21,000
$36,479
+73.71%
$15,479
Frequently Asked Questions
Common questions about DCA investing in RAPP
Investing $500 per month in Rapport Therapeutics, Inc. Common Stock (RAPP) over the past 2 years would be worth approximately $40K today. That's +92.2% total return on $21K invested, with a +40.8% compound annual growth rate (CAGR).